About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 128 record(s)
Req # A-2021-000179
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03758009.Organization: Health Canada
July 2021
Req # A-2021-000180
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03742002.Organization: Health Canada
July 2021
Req # A-2021-000283
Adverse Drug Reaction (ADR) for METFORMIN HYDROCHLORIDE. Report number: E2B_03467451.Organization: Health Canada
July 2021
Req # A-2021-000289
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106091-970, Technical Grade Ethanol in Hand Sanitizers and Hard-Surface Disinfectants.Organization: Health Canada
July 2021
Req # A-2021-000349
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-103397-8, Classification Action within the COVID-19 Vaccine Roll-out Task-Force.Organization: Health Canada
July 2021
Req # A-2021-000406
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-107064-563, Upcoming Publication of Proposed Re-evaluation Decisions and Re-evaluation Decisions for Pesticides.Organization: Health Canada
July 2021
Req # A-2021-000444
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-100088-741, The New Dietary Guidelines for Americans (2020-2025).Organization: Health Canada
July 2021
Req # A-2021-000486
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-107376-390, 2019 Drug and Medical Device Highlights Report to be published on Health Canada's website May 28, 2020.Organization: Health Canada
July 2021
Req # A-2016-000885
All records related to the possibility that self-care product labels may mislead the consumer, as indicated in Health Canada's consultation document entitled "Consulting Canadians on the Regulation of Self-Care Products in Canada", published on Health Canada's website on September 7, 2016.Organization: Health Canada
October 2020
Req # A-2019-001318
Adverse Reaction Reports (AERs) for Mezavant and Mesalazine. Report numbers: E2B_02173512, E2B_02176202, E2B_02196619, 000718959, E2B_02173280.Organization: Health Canada
October 2020